GlassScriptPhysician profile
Yara D Hatem
NPI 1093902538
$1,308.54
in general payments reported to CMS, 2019-2025
15 companies · $676 in 2025
The $676 reported for 2025 was more than what 95% of Women'S Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $153).
See the full distribution for Women's Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $128 · 2024: $505 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,244 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,243.59 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $321.46 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $183.79 | 2024-2025 | |
| Biogen, INC. | $160.39 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $157.20 | 2025 | Novasure, Fluent Fluid Management System |
| Pharmacosmos Therapeutics INC. | $127.31 | 2025 | Monoferric |
| Bayer Healthcare Pharmaceuticals INC. | $86.10 | 2023-2025 | |
| Agile Therapeutics, INC. | $53.01 | 2023 | Twirla |
| Exact Sciences Corporation | $42.25 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Exeltis, USA INC. | $38.18 | 2024-2025 | Slynd |
| Organon LLC | $35.69 | 2024-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $30.78 | 2023 | Myfembree |
| Pfizer INC. | $26.41 | 2025 | |
| Optumhealth Care Solutions, LLC | $19.20 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Abbvie INC. | $18.22 | 2023 | |
| Evofem Biosciences, INC. | $8.55 | 2025 | Phexxi, Solosec, Phexx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yara Hatem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.